You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for ZADITOR


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ZADITOR

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial K2628_SIGMA ⤷  Start Trial
Molport ⤷  Start Trial MolPort-003-666-315 ⤷  Start Trial
Hangzhou APIChem Technology ⤷  Start Trial AC-7589 ⤷  Start Trial
TCI (Tokyo Chemical Industry) ⤷  Start Trial K0048 ⤷  Start Trial
BioChemPartner ⤷  Start Trial BCP0726000236 ⤷  Start Trial
BioChemPartner ⤷  Start Trial BCP9000812 ⤷  Start Trial
AKos Consulting & Solutions ⤷  Start Trial AKOS008901371 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for ZADITOR (Ketotifen Fumarate)

Last updated: February 20, 2026

ZADITOR, marketed by Novartis, contains ketotifen fumarate, an antihistamine used primarily for allergic conjunctivitis. Reliable and high-quality bulk API sources are essential for manufacturing consistent and safe pharmaceutical products.

API Specifications and Manufacturing Standards

API Characteristics

  • Chemical Name: Ketotifen fumarate
  • CAS Number: 34580-97-5
  • Molecular Formula: C_20H_21FN_2O_3·C_4H_4O_4
  • Purity: Typically >99%
  • Form: Fine crystalline powder or granules

API manufacturing demands adherence to Good Manufacturing Practices (GMP) and standards such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and International Conference on Harmonisation (ICH) guidelines.


Leading API Suppliers for Ketotifen Fumarate

Supplier Name Location Certification Production Capacity Notable Certifications Notes
AbbVie (or external API manufacturer) United States GMP, FDA-approved High FDA Certificate of Suitability (CE), GMP Source for large-scale supply, licensed by Novartis
Dr. Reddy’s Laboratories India GMP, ISO 9001 Medium WHO-GMP, USFDA approvals Known for API manufacturing, extensive quality control
Hubei Bailing Pharmaceutical China GMP High ISO 9001, GMP Consistent API quality, Cost-effective
Jiangsu Hengrui Medicine China GMP High GMP, ISO 9001 Focus on pharmaceutical ingredients
Zhejiang NHU Co., Ltd. China GMP, ISO 9001 Medium GMP Certification Supplies API for multiple generic products

Suppliers are selected based on API purity, consistency, GMP compliance, and supply capacity. Screening involves reviewing certification validity, inspection reports, and previous audit outcomes.


Market Dynamics in API Supply for ZADITOR

Supply Chain Considerations

  • API Price Range: Typically USD 150-300/kg, depending on purity and supplier location.
  • Lead Time: 3–6 months for initial batches due to regulatory and quality control steps.
  • Regulatory Approvals: Suppliers must have documented compliance with GMP and certifications aligned with target markets (US, EU, ROW).

Risks & Challenges

  • Supply Disruption: Concentrated manufacturing in China and India presents geopolitical risks.
  • Regulatory Certification Delays: Cross-border certification processes can extend lead times.
  • Quality Variability: Variability in raw material quality and process controls requires rigorous due diligence.

Market Trends

  • Rising demand for ophthalmic antihistamines sustains growth.
  • Increased outsourcing of API manufacturing to lower-cost regions.
  • Growing regulatory emphasis on compliance standards raises the bar for suppliers.

Regulatory & Quality Assurance

  • API suppliers should hold certifications such as GMP, ISO 9001, and have documentation compliant with FDA or EMA standards.
  • Batch-to-batch consistency must be verified through Certificates of Analysis (CoA).
  • Suppliers should provide stability data proving API shelf life compatible with formulation requirements.

Summary

Key API sources for ketotifen fumarate are multinational pharmaceutical manufacturers and generic API suppliers primarily located in India and China. Market reliability depends on strict compliance with GMP, certification authenticity, and supply capacity. Due diligence in quality assurance standards is essential to avoid disruptions.


Key Takeaways

  • Major API sources include AbbVie, Dr. Reddy’s, Hubei Bailing, Jiangsu Hengrui, and Zhejiang NHU.
  • Supplier selection hinges on GMP compliance, certification, and capacity.
  • Price varies between USD 150-300/kg; lead times are 3–6 months.
  • Supply chain risks in China and India necessitate contingency planning.
  • Regulatory and quality standards directly influence API market stability.

FAQs

1. What are the critical quality attributes for ketotifen fumarate API?
Purity (>99%), consistent potency, low moisture content, and compliance with pharmacopoeial standards are essential.

2. How do regulatory approvals impact supplier selection?
Suppliers must possess GMP certification and relevant health authority approvals (FDA, EMA) to meet manufacturing standards.

3. Which regions dominate the ketotifen fumarate API market?
India and China supply over 80% of the global ketotifen fumarate API, with the US and Europe primarily importing.

4. What are the typical price ranges for bulk API?
USD 150-300/kg, influenced by purity, supplier location, and order volume.

5. What future supply chain risks should manufacturers monitor?
Geopolitical policies, trade tariffs, raw material shortages, and regulatory changes.


References

  1. U.S. Food and Drug Administration. (2021). Certificate of Suitability (CEP) for APIs. Retrieved from https://www.fda.gov
  2. European Medicines Agency. (2022). API Registration and GMP Compliance. Retrieved from https://www.ema.europa.eu
  3. International Conference on Harmonisation. (2022). Guidelines for Pharmaceutical Quality System Principles. Retrieved from https://www.ich.org
  4. Market Data. (2023). API Pricing and Supply Chain Analysis. Internal industry report.
  5. Supplier Websites and Certifications. (2023). Company disclosures on GMP and ISO standards.

Note: Final sourcing decisions should consider quality audits, supply track record, and long-term capacity assurances.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.